Amedisys Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Amedisys (AMED) Misses Q1 EPS by 1c; Withdraws Outlook
May 6, 2020 4:26 PM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $0.96, $0.01 worse than the analyst estimate of $0.97. Revenue for the quarter came in at $491.7 million versus the consensus estimate of $504.85 million.
Paul B. Kusserow, President and Chief Executive Officer stated, I am very proud of our first quarter results... More
